Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Michele Zamy"'
Publikováno v:
Revue Francophone des Laboratoires. 2010:85-92
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::654f7ca12dc95d1ae551048c87a71864
https://doi.org/10.1016/s1773-035x(10)70696-1
https://doi.org/10.1016/s1773-035x(10)70696-1
Autor:
Olivier Fain, M. Gerin, Arsène Mekinian, P. Nahon, Michele Zamy, H. Mouas, A. Diallo, L. Boukari
Publikováno v:
La Revue de Médecine Interne. 34:168-170
Resume Introduction La maladie de Still de l’adulte (MSA) est une affection caracterisee par un tableau clinique polymorphe aspecifique. L’efficacite de l’anakinra, inhibiteur du recepteur de l’IL-1, a ete demontree dans plusieurs series. La
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93e3ea5039ec211ea39465cabcada42e
https://doi.org/10.1016/j.revmed.2012.10.372
https://doi.org/10.1016/j.revmed.2012.10.372
Autor:
J.-J. Mourad, S. Le Jeune, Tiphaine Goulenok, H. Cordel, E. Mazoyer, C. Rouyer, M. Lemaître, O. Pointeau, Michele Zamy, S. Marot, F. Pousset, Jaehyo Suhl
Publikováno v:
La Revue de Médecine Interne. 37:A171-A172
Introduction Le deficit acquis en facteur V est une pathologie rare et encore peu decrite. La revue systematique de la litterature la plus recente, realisee en 2011, presente 74 cas. Le plus souvent, le deficit acquis en facteur V s’associe a des c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fdcb2f3bbc78a462c4873ab6123e970
https://doi.org/10.1016/j.revmed.2016.04.165
https://doi.org/10.1016/j.revmed.2016.04.165
Autor:
Bouraoui Elouni, Michel Beaugrand, Nathalie Ganne, Chaker Ben Salem, Michele Zamy, Kamel Bouraoui, Michel Biour
Publikováno v:
Annals of Pharmacotherapy. 44:2035-2037
This letter to the editor reports on two cases of biopsy-confirmed cytolytic hepatitis induced by a levonorgestrel/ethinylestradiol combination oral contraceptive pill.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c84f82c881a1aa2de32ec926b1f8a1c5
https://doi.org/10.1345/aph.1p201
https://doi.org/10.1345/aph.1p201
Autor:
Sarah, Mattioni, Michele, Zamy, Frederic, Mechai, Jean-Jacques, Raynaud, Amelie, Chabrol, Vanessa, Aflalo, Michel, Biour, Olivier, Bouchaud
Publikováno v:
JOP : Journal of the pancreas. 13(3)
Drug induced pancreatitis are rare but potentially serious. Thus, drug withdrawal is warranted.A 79-year-old woman who was treated with antituberculosis therapy for 5 weeks was admitted to our unit for pancreatitis. Usual etiologies of pancreatitis w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aaa5e56d8ec3864c813538626af9fa05
https://pubmed.ncbi.nlm.nih.gov/22572141
https://pubmed.ncbi.nlm.nih.gov/22572141
Autor:
Neila, Fathallah, Michele, Zamy, Raoudha, Slim, Olivier, Fain, Houssem, Hmouda, Kamel, Bouraoui, Chaker, Ben Salem, Michel, Biour
Publikováno v:
JOP : Journal of the pancreas. 12(4)
We report a case of massive poisoning with meprobamate leading to acute pancreatitis.A 43-year-old patient with a history of schizophrenia and multiple suicide attempts was admitted to the intensive care unit for severe poisoning with meprobamate (vo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3804a6675369b35c67fea15a4250b9f9
https://pubmed.ncbi.nlm.nih.gov/21737904
https://pubmed.ncbi.nlm.nih.gov/21737904
Autor:
Michele Zamy, M. Gerin, G. Chaine, Arsène Mekinian, A. Temine, P. Agranat, L. Boukari, O. Brault-Meslin, Olivier Fain, Jérôme Stirnemann
Publikováno v:
La Revue de Médecine Interne. 32:S186-S187
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68933c8e49e3c433d2ddd017ea44a666
https://doi.org/10.1016/j.revmed.2011.03.322
https://doi.org/10.1016/j.revmed.2011.03.322
Publikováno v:
Annals of Pharmacotherapy. 44:1348-1349
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b02cc73effd501c9ce163bbc9bf0d23
https://doi.org/10.1345/aph.1p186
https://doi.org/10.1345/aph.1p186
Publikováno v:
Diabetes Care
Pioglitazone, a peroxisome proliferator–activated receptor γ agonist, is a relatively new oral antidiabetes agent. It has been shown to decrease insulin resistance in patients with type 2 diabetes, resulting in lowered blood glucose concentrations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f668cbe442339d823b1ead95c624a01e
https://doi.org/10.2337/dc09-0593
https://doi.org/10.2337/dc09-0593